Ibalizumab

TargetMol
Product Code: TAR-T76687
Product Group: Primary Antibodies
Supplier: TargetMol
CodeSizePrice
TAR-T76687-1mg1mg£871.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T76687-5mg5mg£2,472.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T76687-10mg10mg£3,251.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T76687-25mg25mg£4,793.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Antibody Clonality: Monoclonal
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C

Images

1 / 1

Further Information

Bioactivity:
Ibalizumab(TMB-355) is a humanized IgG4 monoclonal antibody that acts as a CD4 receptor inhibitor, blocking the entry of HIV-1 into cells by binding to the CD4 receptor.Ibalizumab has anti-HIV-1 infectious activity and may be used to maintain normal immune function.
CAS:
680188-33-4
Pathway:
Proteases/Proteasome|Microbiology/Virology
Purity:
0.98
Target:
HIV Protease

References

Anthony Markham. Ibalizumab: First Global Approval. Drugs. 2018 May;78(7):781-785.